MENU
+Compare
ACRV
Stock ticker: NASDAQ
AS OF
Jun 26 closing price
Price
$1.31
Change
-$0.02 (-1.50%)
Capitalization
41.08M

ACRV Acrivon Therapeutics Forecast, Technical & Fundamental Analysis

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform... Show more

ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ACRV with price predictions
Jun 25, 2025

ACRV in +12.71% Uptrend, rising for three consecutive days on June 25, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ACRV advanced for three days, in of 135 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 38 cases where ACRV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 25, 2025. You may want to consider a long position or call options on ACRV as a result. In of 52 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Bearish Trend Analysis

ACRV broke above its upper Bollinger Band on June 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ACRV entered a downward trend on June 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.256) is normal, around the industry mean (16.539). P/E Ratio (0.000) is within average values for comparable stocks, (59.016). ACRV's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.300). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (255.605).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ACRV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACRV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ACRV is expected to report earnings to rise 113.73% to -109 cents per share on August 08

Acrivon Therapeutics ACRV Stock Earnings Reports
Q2'25
Est.
$-1.09
Q1'25
Beat
by $0.50
Q4'24
Beat
by $0.17
Q3'24
Beat
by $0.15
Q2'24
Beat
by $0.23
The last earnings report on May 15 showed earnings per share of -50 cents, beating the estimate of -100 cents. With 438.53K shares outstanding, the current market capitalization sits at 41.08M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 207-8979
Employees
61
Web
https://www.acrivon.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GIII22.490.74
+3.40%
G-III Apparel Group Ltd
ELP9.030.16
+1.80%
Companhia Paranaense de Energia - COPEL
HIVE1.790.01
+0.56%
HIVE Digital Technologies Ltd
AON353.55-0.91
-0.26%
Aon plc
GRCE2.94-0.02
-0.68%
Grace Therapeutics Inc

ACRV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRV has been loosely correlated with ALLR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRV jumps, then ALLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRV
1D Price
Change %
ACRV100%
+7.26%
ALLR - ACRV
48%
Loosely correlated
-5.71%
AURA - ACRV
40%
Loosely correlated
+0.31%
MGNX - ACRV
38%
Loosely correlated
-2.24%
CCCC - ACRV
38%
Loosely correlated
-1.28%
ARWR - ACRV
37%
Loosely correlated
-1.88%
More